Cochlear drove revenue to record heights in the full year to June to post a 56% rise to $145.8 million in net profits.
The hearing device group hit record sales of $941.9 million, up 15%. Cochlear implant sales were 26,838, up 3%.
However, the profit was below analyst expectations of $156.1 million.
CEO Chris Roberts says sales in the second half were $501 million, up 14% on the first six months.
“This sales momentum also confirms the success of products rolled out across all product categories over the last two years, supported by a range of market expansion activities including broadened clinical indications and roll-out of online activities,” Roberts said.
The profit guidance for 2016 is for a net profit range of between $165 million and $175 million.
A final fully franked dividend of $1.00 per share was declared.